LENZ Therapeutics News

LENZ Therapeutics | 8-K: Current report

Jul 15 08:24 ET

LENZ Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 21 08:35 ET

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 8 16:10 ET

LENZ Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 9 14:30 ET

LENZ Therapeutics | 8-K: Current report

Apr 3 07:37 ET

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 29 16:48 ET

Therapeutics | 8-K: Current report

Mar 22 14:11 ET

Graphite Bio | 8-K: Current report

Mar 19 16:37 ET

Graphite Bio | 8-K: Current report

Mar 14 16:41 ET

Graphite Bio | 8-K: Current report

Mar 8 17:17 ET

Graphite Bio | 8-K: Current report

Mar 5 06:12 ET

Graphite Bio | 8-K: Current report

Dec 26, 2023 00:00 ET

Graphite Bio | 8-K: Current report

Nov 15, 2023 08:06 ET

Graphite Bio | 8-K: Current report

Oct 30, 2023 16:08 ET

Graphite Bio | 8-K/A: Current report (Amendment)

Sep 13, 2023 16:06 ET

Graphite Bio | 8-K: Current report

Aug 23, 2023 16:06 ET

Graphite Bio | 8-K: Current report

Aug 2, 2023 16:07 ET

Graphite Bio | 8-K: Current report

Jul 20, 2023 08:02 ET

Graphite Bio | 8-K: Current report

Jun 23, 2023 07:05 ET

Graphite Bio | DEFA14A: Others

Jun 6, 2023 16:12 ET